Plexus Corp. (NASDAQ:PLXS – Get Free Report) CFO Patrick John Jermain sold 4,328 shares of the business’s stock in a transaction on Thursday, May 15th. The stock was sold at an average price of $132.29, for a total value of $572,551.12. Following the transaction, the chief financial officer now directly owns 25,637 shares in the company, valued at $3,391,518.73. This trade represents a 14.44% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.
Plexus Price Performance
NASDAQ:PLXS opened at $132.95 on Tuesday. The company has a market capitalization of $3.60 billion, a P/E ratio of 30.85 and a beta of 0.80. The company has a quick ratio of 0.70, a current ratio of 1.53 and a debt-to-equity ratio of 0.07. Plexus Corp. has a 52 week low of $100.96 and a 52 week high of $172.89. The stock’s fifty day moving average is $125.09 and its two-hundred day moving average is $142.92.
Plexus (NASDAQ:PLXS – Get Free Report) last issued its quarterly earnings data on Wednesday, April 23rd. The technology company reported $1.66 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.54 by $0.12. The firm had revenue of $980.17 million for the quarter, compared to analyst estimates of $980.07 million. Plexus had a net margin of 3.03% and a return on equity of 10.36%. Plexus’s revenue was up 1.4% on a year-over-year basis. During the same period in the previous year, the firm earned $0.94 EPS. Equities analysts expect that Plexus Corp. will post 5.9 EPS for the current year.
Hedge Funds Weigh In On Plexus
Analyst Ratings Changes
Several research analysts have recently commented on PLXS shares. Needham & Company LLC reiterated a “buy” rating and set a $162.00 price target (down previously from $172.00) on shares of Plexus in a report on Friday, April 25th. Benchmark reaffirmed a “buy” rating and set a $160.00 target price on shares of Plexus in a research note on Friday. Finally, Stifel Nicolaus set a $145.00 target price on shares of Plexus in a report on Thursday, April 24th. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, Plexus currently has an average rating of “Moderate Buy” and an average price target of $155.67.
View Our Latest Report on Plexus
Plexus Company Profile
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Recommended Stories
- Five stocks we like better than Plexus
- What is Short Interest? How to Use It
- UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?
- What Does Downgrade Mean in Investing?
- What Ray Dalio’s Latest Moves Tell Investors
- Energy and Oil Stocks Explained
- Amazon: Why May Is the Last Month to Get the Stock at a Discount
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.